Aurobindo Ramps Up In Biosimilars With UK Bevacizumab Nod

CuraTeQ Subsidiary Receives MHRA Approval For Bevqolva Rival To Avastin

 
• By Dave Wallace

Aurobindo’s biosimilars business is continuing to gain momentum, with a UK approval for bevacizumab in hand and further European nods expected.

Aurobindo has picked up an MHRA nod for bevacizumab (Shutterstock)

More from Biosimilars

More from Generics Bulletin